Klingman & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
Klingman & Associates's TMO Position: Q3 2026 in Review
Klingman & Associates increased its Thermo Fisher Scientific (TMO) stake by 2.3% in Q3 2026, buying an estimated $26.1K and bringing the position to 1,940 shares worth $1.31M. The position accounts for 0.05% of the portfolio, ranked #120.
Klingman & Associates first reported a position in TMO in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.94M in Q3 2024. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Klingman & Associates held 1,940 shares of Thermo Fisher Scientific worth $1.31M as of Q3 2026.
- Klingman & Associates bought 44 Thermo Fisher Scientific shares in Q3 2026, an estimated $26.1K.
- Thermo Fisher Scientific made up 0.05% of Klingman & Associates's portfolio in Q3 2026, its #120 holding.
- Klingman & Associates first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 27 quarters since.
- Klingman & Associates's Thermo Fisher Scientific position peaked at $1.94M in Q3 2024.
- 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.